Literature DB >> 15677471

The STAT3 transcription factor is a target for the Myc and riboblastoma proteins on the Cdc25A promoter.

Benjamin Barré1, Arnaud Vigneron, Olivier Coqueret.   

Abstract

The STAT3 (signal transducer and activator of transcription) transcription factor functions as down-stream effector of growth factor signaling. Whereas STAT3 activation is transient in normal cells, constitutively activated forms of the transcription factor have been detected in several cancer cell lines and primary tumors. Through the up-regulation of cell cycle and survival genes, STAT3 plays important roles in cell growth, anti-apoptosis, and cell transformation yet the molecular basis for this behavior is poorly understood. In this study, we show that STAT3 and its transcriptional cofactors are recruited to the promoter of the Cdc25A gene to activate its expression. Using chromatin immunoprecipitations, we observed that Myc is recruited to this promoter following STAT3 DNA binding. Moreover, small interfering RNA-mediated knockdown of Myc specifically inhibits the STAT3-mediated activation of Cdc25A. Reduction in Myc protein level results in defective recruitment of the CREB-binding protein, Cdk9, and RNA polymerase complexes, indicating that Myc is necessary for STAT3 transcription. Surprisingly, the association of STAT3 with the Cdc25A promoter does not necessarily lead to transcriptional induction because this protein also functions as a transcriptional repressor of the Cdc25A gene. Following hydrogen peroxide stimulation, STAT3 forms a repressor complex with the retinoblastoma (Rb) tumor suppressor to occupy the Cdc25A promoter and block its induction. In coimmunoprecipitations and ChIP experiments, Rb was found to associate with STAT3 on DNA and we provide evidence that Rb binds directly to the transcription factor. Thus, we propose that Myc and STAT3 cooperate to induce the expression of Cdc25A and that their transcriptional activity is normally regulated by the Rb tumor suppressor gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15677471     DOI: 10.1074/jbc.M413203200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma.

Authors:  Gerald C Wallace; Yaenette N Dixon-Mah; W Alex Vandergrift; Swapan K Ray; Catherine P Haar; Amber M Mittendorf; Sunil J Patel; Naren L Banik; Pierre Giglio; Arabinda Das
Journal:  Metab Brain Dis       Date:  2013-04-02       Impact factor: 3.584

Review 2.  The role of Cdc25A in the regulation of cell proliferation and apoptosis.

Authors:  Tao Shen; Shile Huang
Journal:  Anticancer Agents Med Chem       Date:  2012-07       Impact factor: 2.505

Review 3.  PI3K and STAT3: a new alliance.

Authors:  Peter K Vogt; Jonathan Ross Hart
Journal:  Cancer Discov       Date:  2011-11       Impact factor: 39.397

4.  Characterisation of HRas local signal transduction networks using engineered site-specific exchange factors.

Authors:  Ana Herrero; Mariana Reis-Cardoso; Iñaki Jiménez-Gómez; Carolanne Doherty; Lorena Agudo-Ibañez; Adán Pinto; Fernando Calvo; Walter Kolch; Piero Crespo; David Matallanas
Journal:  Small GTPases       Date:  2018-01-15

5.  Zipper-interacting protein kinase (ZIPK) modulates canonical Wnt/beta-catenin signaling through interaction with Nemo-like kinase and T-cell factor 4 (NLK/TCF4).

Authors:  Sumihito Togi; Osamu Ikeda; Shinya Kamitani; Misa Nakasuji; Yuichi Sekine; Ryuta Muromoto; Asuka Nanbo; Kenji Oritani; Taro Kawai; Shizuo Akira; Tadashi Matsuda
Journal:  J Biol Chem       Date:  2011-03-30       Impact factor: 5.157

6.  microRNA-133a attenuates cardiomyocyte hypertrophy by targeting PKCδ and Gq.

Authors:  Se-Yeon Lee; Chang Youn Lee; Onju Ham; Jae Yoon Moon; Jiyun Lee; Hyang-Hee Seo; Sunhye Shin; Sang Woo Kim; Seahyoung Lee; Soyeon Lim; Ki-Chul Hwang
Journal:  Mol Cell Biochem       Date:  2017-08-09       Impact factor: 3.396

7.  The cdk5 kinase regulates the STAT3 transcription factor to prevent DNA damage upon topoisomerase I inhibition.

Authors:  Sandy Courapied; Hélène Sellier; Sophie de Carné Trécesson; Arnaud Vigneron; Anne-Charlotte Bernard; Erick Gamelin; Benjamin Barré; Olivier Coqueret
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

8.  Transcriptional profiling of intrinsic PNS factors in the postnatal mouse.

Authors:  Robin P Smith; Jessica K Lerch-Haner; Jose R Pardinas; William J Buchser; John L Bixby; Vance P Lemmon
Journal:  Mol Cell Neurosci       Date:  2010-08-07       Impact factor: 4.314

9.  IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer.

Authors:  J Guo; D Kim; J Gao; C Kurtyka; H Chen; C Yu; D Wu; A Mittal; A A Beg; S P Chellappan; E B Haura; J Q Cheng
Journal:  Oncogene       Date:  2012-02-13       Impact factor: 9.867

10.  Role of LIM kinases in normal and psoriatic human epidermis.

Authors:  Masaru Honma; Salvador Aznar Benitah; Fiona M Watt
Journal:  Mol Biol Cell       Date:  2006-02-08       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.